Steroid-Refractory Bullous Pemphigoid Following Leuprolide Acetate in a Patient With Multiple Sclerosis
-
November 3, 2026
November 3, 2026
November 3, 2026
October 14, 2026
None of the 3 symptomatic patients knew the injected product lacked FDA approval.
by Teraya Smith
October 9, 2026